The global blood culture test market reached a value of US$ 4.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.1 Billion by 2027, exhibiting a CAGR of 8.77% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

A blood culture test refers to a medical procedure that is conducted to diagnose bacterial, fungal and mycobacterial infections. It is performed for the identification of various microorganisms in the blood sample and for preventing the development of sepsis conditions. The results of the culture test can aid in determining the specific pathogens that are causing the infection and possible ways for combating the disease. It utilizes products including blood culture media, assay kits, reagents, and blood culture accessories, and instruments such as automated blood culture systems and supporting laboratory equipment.

Blood Culture Test Market Trends:
The increasing prevalence of chronic and infectious diseases across the globe is one of the key factors driving the growth of the market. Furthermore, the growing geriatric population that is more susceptible to sepsis and other medical ailments is also providing a boost to the market growth. Additionally, the growing demand for blood culture tests to analyze specimens, due to the outbreak of the COVID-19 pandemic, is acting as another major growth-inducing factor. Laboratories, diagnostic centers and other healthcare institutes are now increasingly using these tests for detecting the presence of antibodies in the blood and identifying and isolating the infected individuals. Other factors, including the rising health consciousness among the masses, improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood culture test market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on testing medthod, product, technology, application and end-user.

Breakup by Testing Method:

Conventional
Automated

Breakup by Product:

Consumables
Blood Culture Media
Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Fungi/Yeast Blood Culture Media
Mycobacteria Blood Culture Media
Assay Kits and Reagents
Blood Culture Accessories
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Services

Breakup by Technology:

Culture-based Technology
Molecular Technology
Microarray
PCR
PNA-FISH
Proteomic Technology
Others

Breakup by Application:

Bacterial Infections
Fungal Infections
Mycobacterial Infections

Breakup by End-User:

Hospital Laboratories
Reference Laboratories
Research Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, bioMeriux SA, Bruker Corporation, Luminex Corporation, Merck KGaA, Siemens Healthcare GmbH, F.Hoffmann-La Roche Ltd., T2 Biosystems Inc. and Thermo Fisher Scientific Company.

Key questions answered in this report:
How has the global blood culture test market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global blood culture test market?
What is the breakup of the market based on the testing method?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global blood culture test market and who are the key players?
What is the degree of competition in the industry?